Moderna
MRNA
#1308
Rank
HK$134.53 B
Marketcap
HK$344.31
Share price
-5.95%
Change (1 day)
12.05%
Change (1 year)
Moderna, Inc. is an American biotechnology company focused on the discovery and development of messenger RNA-based drugs.

Market capitalization of Moderna (MRNA)

Market cap: HK$134.53 Billion

As of February 2026 Moderna has a market cap of HK$134.53 Billion. This makes Moderna the world's 1308th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Moderna from 2018 to 2026

End of year Market Cap

Year Marketcap Change
2026HK$134.53 B41.83%
2025HK$94.85 B-20.88%
2024HK$119.88 B-59.52%
2023HK$296.14 B-45.07%
2022HK$539.16 B-32.85%
2021HK$802.96 B150.55%
2020HK$320.47 B525.11%
2019HK$51.26 B30.39%
2018HK$39.31 B

End of Day market cap according to different sources

On Jan 31st, 2026 the market cap of Moderna was reported to be:

HK$134.51 Billion
by Nasdaq info icon info icon
HK$134.53 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Johnson & Johnson
JNJ
HK$4.277 T 3,079.58%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
HK$2.228 T 1,556.75%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Merck
MRK
HK$2.151 T 1,499.51%๐Ÿ‡บ๐Ÿ‡ธ USA
Regulus Therapeutics
RGLS
HK$4.41 B-96.72%๐Ÿ‡บ๐Ÿ‡ธ USA
Dicerna Pharmaceuticals
DRNA
HK$23.26 B-82.71%๐Ÿ‡บ๐Ÿ‡ธ USA
Athersys
ATHX
HK$6.5 M-100.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
HK$348.93 B 159.37%๐Ÿ‡บ๐Ÿ‡ธ USA
Arrowhead Pharmaceuticals
ARWR
HK$75.83 B-43.63%๐Ÿ‡บ๐Ÿ‡ธ USA